Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol. (2013)
Attributed to:
CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/2047-1440-2-7
PubMed Identifier: 23641902
Publication URI: http://europepmc.org/abstract/MED/23641902
Type: Journal Article/Review
Volume: 2
Parent Publication: Transplantation research
Issue: 1
ISSN: 2047-1440